Literature DB >> 11512581

Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.

K Abe1, M Takanashi, Y Watanabe, H Tanaka, N Fujita, N Hirabuki, T Yanagihara.   

Abstract

We studied whether N-acetylaspartate (NAA), a neuronal marker, is reduced in the brain of 14 patients with clinically definite amyotrophic lateral sclerosis (ALS) and whether NAA levels in the motor area and frontal lobe correlate with the clinical features, including frontal lobe function. We also studied 14 normal controls were evaluated. We obtained peak integrals in 1H magnetic resonance spectroscopy (MRS) for NAA, creatine (Cr), and choline-containing compounds (Cho). Severity of the disease was determined using the manual muscle strength test, and the Norris limb and bulbar scales. In the patients, the NAA/Cr ratio was reduced in the motor area and frontal lobe, while the Cho/Cr ratio was normal throughout the brain. There were significant correlations between the NAA/Cr ratio in the motor area and the Norris limb scale (r = 0.50; P < 0.01) and between the NAA/Cr ratio in the frontal lobe and the number of categories achieved in the Wisconsin Card Sorting test (r = 0.71; P < 0.05), implying frontal lobe dysfunction. These correlations suggest that a reduced NAA/Cr ratio is a marker of cortical neuronal loss and dysfunction in ALS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512581     DOI: 10.1007/s002340000521

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  20 in total

Review 1.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

2.  Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

Authors:  Hongxia Lei; Elisabeth Dirren; Carole Poitry-Yamate; Bernard L Schneider; Rolf Gruetter; Patrick Aebischer
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-05       Impact factor: 6.200

3.  Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.

Authors:  J D Carew; G Nair; P M Andersen; J Wuu; S Gronka; X Hu; M Benatar
Journal:  Neurology       Date:  2011-09-21       Impact factor: 9.910

4.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.

Authors:  Stefan Sivák; Michal Bittšanský; Egon Kurča; Monika Turčanová-Koprušáková; Milan Grofik; Vladimír Nosál'; Hubert Poláček; Dušan Dobrota
Journal:  Neuroradiology       Date:  2010-04-06       Impact factor: 2.804

5.  Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability.

Authors:  F Agosta; E Pagani; M A Rocca; D Caputo; M Perini; F Salvi; A Prelle; M Filippi
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

6.  Gray matter perfusion correlates with disease severity in ALS.

Authors:  Randall R Rule; Norbert Schuff; Robert G Miller; Michael W Weiner
Journal:  Neurology       Date:  2010-02-10       Impact factor: 9.910

7.  Cerebral energetic effects of creatine supplementation in humans.

Authors:  J W Pan; K Takahashi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-21       Impact factor: 3.619

8.  Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways.

Authors:  Biba R Stanton; V C Williams; P N Leigh; Steven C R Williams; C R V Blain; J M Jarosz; Andrew Simmons
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

9.  Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS.

Authors:  Colin Quinn; Lauren Elman; Leo McCluskey; Katelin Hoskins; Chafic Karam; John H Woo; Harish Poptani; Sumei Wang; Sanjeev Chawla; Scott E Kasner; Murray Grossman
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 10.  25 years of neuroimaging in amyotrophic lateral sclerosis.

Authors:  Bradley R Foerster; Robert C Welsh; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2013-08-06       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.